FacebookTwitter

Seminar: March 19, 2015

Además,  a continuación del seminario invitamos a los interesados a participar en una actividad que llamamos “meet the speaker” con el relator invitado donde podrán conversar el tema y otros aspectos relevantes en mas detalle con el relator. Agradeceremos a los interesados en participar en esta actividad registrarse a mas tardar el día anterior a los siguientes […]

Chilean scientist discovers compound that reduces insulin resistance

The compound methyl-B-cyclodextrin reduces insulin resistance, disease that silently attacks to 22 percent of Chilean people. This discovery was made by a group of researchers of the Nemesis Ring of the University of Chile, led by Dr. Paola Llanos. This news was posted on January 10 in daily Las Ultimas Noticias…  

Annual Meeting NEMESIS Ring ACT1111

During a Meeting that brought together more than forty researchers NEMESIS scientists presented research advances in the areas of cancer, diabetes and cardiovascular diseases Of particular interest were recent findings related to a new drug for the treatment of insulin resistance and the importance of exercise in treatment of many chronic pathologies.  Non-communicable diseases are […]

ACCDiS INTERNATIONAL THEORETICAL AND PRACTICAL COURSE: METABOLIC SIGNALING AND CHRONIC DISEASES

Dates: October 5-9th, 2015 Place: Advanced Center for Chronic Diseases (ACCDiS) Facultad Ciencias Químicas y Farmacéuticas, Universidad de Chile, Olivos 1007, Santiago, Chile 2015  Organizer: Sergio Lavandero, PhD (ACCDiS, Universidad de Chile) Coordinators: Mario Chiong, PhD (ACCDiS, Universidad de Chile) Rodrigo Troncoso, PhD (ACCDiS, Universidad de Chile) Lorena García, PhD (ACCDiS, Universidad de Chile, Chile) Topics Energy Metabolism Organelle and […]